UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q1 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $7,533,000 | -50.5% | 208,500 | -49.6% | 0.16% | -58.5% |
| Q3 2020 | $15,227,000 | -17.0% | 413,433 | +1.5% | 0.39% | -23.3% |
| Q2 2020 | $18,345,000 | -3.3% | 407,133 | +1.8% | 0.50% | -35.9% |
| Q1 2020 | $18,980,000 | -33.8% | 400,000 | 0.0% | 0.78% | -13.4% |
| Q4 2019 | $28,664,000 | +274.4% | 400,000 | +105.7% | 0.91% | +197.0% |
| Q3 2019 | $7,656,000 | – | 194,500 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 955,424 | $32,188,000 | 5.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 282,034 | $9,490,000 | 2.51% |
| Nantahala Capital Management | 1,672,891 | $56,360,000 | 1.65% |
| Henry James International Management Inc. | 149,053 | $5,022,000 | 1.51% |
| Nantahala Capital Management | 1,500,000 | $50,535,000 | 1.48% |
| Voss Capital, LLC | 90,000 | $3,032,000 | 1.26% |
| P.A.W. CAPITAL CORP | 30,000 | $1,011,000 | 0.89% |
| Sofinnova Investments, Inc. | 427,122 | $14,390,000 | 0.86% |
| Caption Management, LLC | 1,078,800 | $36,343,000 | 0.78% |
| Sivik Global Healthcare LLC | 61,768 | $2,081,000 | 0.76% |